Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cancer Pain × Morphine × Clear all

Phase

Status

Completed 10 Terminated 2 Withdrawn 1 Unknown 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Wounds and Injuries 1 Ulcer 1 Skin Ulcer 1 Chronic Pain 1 Cancer Pain 1 Adenocarcinoma 1

Interventions

resiniferatoxin 1 Standard of Care 1 Passive Cutaneous Anaphylaxis 1 Morphine 1 Methadone 1 Infusions, Intravenous 1 Administration, Sublingual 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡